Cargando…

Measurement properties of brief neuropathy screening items in cancer patients receiving taxanes, platinums, or proteasome inhibitors

BACKGROUND: Timely detection of chemotherapy-induced peripheral neuropathy (CIPN) is critical to effectively tailor chemotherapy dose levels and offer supportive care. The purpose of this secondary analysis was to determine the reliability and validity of the two Patient-Reported Outcomes Version of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Knoerl, Robert, Mazzola, Emanuele, Mitchell, Sandra A., Hong, Fangxin, Salehi, Elahe, McCleary, Nadine, Ligibel, Jennifer A., Reyes, Kaitlen, Berry, Donna L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473487/ https://www.ncbi.nlm.nih.gov/pubmed/34568984 http://dx.doi.org/10.1186/s41687-021-00377-z

Ejemplares similares

Exploring the impact of a decision support algorithm to improve clinicians’ chemotherapy-induced peripheral neuropathy assessment and management practices: a two-phase, longitudinal study
por: Knoerl, Robert, et al.
Publicado: (2021)

Identifying participants’ preferences for modifiable chemotherapy-induced peripheral neuropathy prevention clinical trial factors: an adaptive choice-based conjoint analysis
por: Knoerl, Robert, et al.
Publicado: (2022)

Yoga for chronic chemotherapy-induced peripheral neuropathy pain: a pilot, randomized controlled trial
por: Knoerl, Robert, et al.
Publicado: (2021)

Impact of Electronic Self-Assessment and Self-Care Technology on Adherence to Clinician Recommendations and Self-Management Activity for Cancer Treatment–Related Symptoms: Secondary Analysis of a Randomized Controlled Trial
por: Knoerl, Robert, et al.
Publicado: (2019)

Risk factors for chemotherapy‐induced peripheral neuropathy in patients receiving taxane‐ and platinum‐based chemotherapy
por: Molassiotis, Alex, et al.
Publicado: (2019)

Hypersensitivity Reactions to Platinum Agents and Taxanes
por: Tsao, Lulu R., et al.
Publicado: (2021)

A Prospective Study of Taxane-Induced Neuropathy with Breast Cancer: Proper Assessment Tool for Taxane-Induced Neuropathy
por: Sohn, Eun Hee, et al.
Publicado: (2021)

Platinum drugs and taxanes: can we overcome resistance?
por: Sazonova, Elena V., et al.
Publicado: (2021)

Melatonin, a Promising Role in Taxane-Related Neuropathy
por: Nahleh, Z., et al.
Publicado: (2010)

The impact of SBF2 on taxane-induced peripheral neuropathy
por: Cunningham, Geneva M., et al.
Publicado: (2022)

Proteasome inhibition reverses hedgehog inhibitor and taxane resistance in ovarian cancer
por: Steg, Adam D., et al.
Publicado: (2014)

Item response theory analysis and properties of decisional conflict scales: findings from two multi-site trials of men with localized prostate cancer
por: Pozzar, Rachel A., et al.
Publicado: (2019)

Taxanes and platinum derivatives impair Schwann cells via distinct mechanisms
por: Imai, Satoshi, et al.
Publicado: (2017)

Items in Brief
Publicado: (1873)

Items in Brief
Publicado: (1878)

Items in Brief
Publicado: (1873)

Overview of neuropathy associated with taxanes for the treatment of metastatic breast cancer
por: Rivera, Edgardo, et al.
Publicado: (2015)

Cryotherapy for Prevention of Taxane-Induced Peripheral Neuropathy: A Meta-Analysis
por: Jia, Junting, et al.
Publicado: (2021)

What do the data say about chemotherapy-induced peripheral neuropathy assessment and management?
por: Kanzawa-Lee, Grace, et al.
Publicado: (2022)

Palliative chemotherapy in carcinoma penis: Does platinum and taxane combination holds a promise?
por: Patil, Vijay M, et al.
Publicado: (2014)

Determination of BRCAness Phenotype in Breast Tumors for the Appointment of Neoadjuvant Chemotherapy Based on Platinum and Taxanes
por: Tsyganov, Matvey Mihajlovich, et al.
Publicado: (2022)

Correlates of Taxane-Induced Neuropathy, an Electronic Health Record Based Observational Study
por: Dorand, R. Dixon, et al.
Publicado: (2023)

TP53 status and taxane-platinum versus platinum-based therapy in ovarian cancer patients: A non-randomized retrospective study
por: Kupryjanczyk, Jolanta, et al.
Publicado: (2008)

Exploring the efficacy of an electronic symptom assessment and self-care intervention to preserve physical function in individuals receiving neurotoxic chemotherapy
por: Knoerl, Robert, et al.
Publicado: (2018)

Correction to: Exploring the efficacy of an electronic symptom assessment and self-care intervention to preserve physical function in individuals receiving neurotoxic chemotherapy
por: Knoerl, Robert, et al.
Publicado: (2019)

Low-dose-intensity bevacizumab with weekly irinotecan for platinum- and taxanes-resistant epithelial ovarian cancer
por: Liu, Ying, et al.
Publicado: (2015)

Taxane-Induced Neuropathy and Its Ocular Effects—A Longitudinal Follow-up Study in Breast Cancer Patients
por: Stache, Nadine, et al.
Publicado: (2023)

Chemotherapy-Induced Peripheral Neuropathy (CIPN) in Patients Receiving 4–6 Cycles of Platinum-Based and Taxane-Based Chemotherapy: A Prospective, Single-Center Study from Kosovo
por: Myftiu, Blerim, et al.
Publicado: (2022)

Lessons learned from the delivery of virtual integrative oncology interventions in clinical practice and research during the COVID-19 pandemic
por: Knoerl, Robert, et al.
Publicado: (2021)

Investigating the Effect of Zinc on the Prevention of Acute Peripheral Neuropathy in Cancer Patients Treated with Taxanes
por: Haji Gholami, Ali, et al.
Publicado: (2022)

Effects of platinum/taxane based chemotherapy on acute perfusion in human pelvic tumours measured by dynamic MRI
por: Lankester, K J, et al.
Publicado: (2005)

Nuclear survivin expression is a positive prognostic factor in taxane-platinum-treated ovarian cancer patients
por: Felisiak-Golabek, Anna, et al.
Publicado: (2011)

Vinorelbine Plus Platinum in Patients with Metastatic Triple Negative Breast Cancer and Prior Anthracycline and Taxane Treatment
por: li, Meiying, et al.
Publicado: (2015)

Comprehensive review on how platinum- and taxane-based chemotherapy of ovarian cancer affects biology of normal cells
por: Mikuła-Pietrasik, Justyna, et al.
Publicado: (2018)

Platinum-containing compound platinum pyrithione suppresses ovarian tumor proliferation through proteasome inhibition
por: Huang, Hongbiao, et al.
Publicado: (2017)

Comparison of Efficacy and Safety of Taxanes Plus Platinum and Fluorouracil Plus Platinum in the First-Line Treatment of Esophageal Cancer: A Systematic Review and Meta-Analysis
por: Zhao, Yue, et al.
Publicado: (2022)

Adjuvant therapy of endometrial cancer: “taxane or not taxane, this is the question”
por: Lorusso, Vito, et al.
Publicado: (2019)

Identifying Predictors of Taxane-Induced Peripheral Neuropathy Using Mass Spectrometry-Based Proteomics Technology
por: Chen, Emily I., et al.
Publicado: (2015)

Acupuncture for the Treatment of Taxane-Induced Peripheral Neuropathy in Breast Cancer Patients: A Pilot Trial
por: Jeong, Young Ju, et al.
Publicado: (2018)

Platinum type is key in determining degree of neuropathy
por: Muggia, Franco, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7omo5ddmc7n6bmto2koub57h14